Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding

  1. R Christopher D Furniss
  2. Nikol Kaderabkova
  3. Declan Barker
  4. Patricia Bernal
  5. Evgenia Maslova
  6. Amanda AA Antwi
  7. Helen E McNeil
  8. Hannah L Pugh
  9. Laurent Dortet
  10. Jessica MA Blair
  11. Gerald J Larrouy-Maumus
  12. Ronan R McCarthy
  13. Diego Gonzalez
  14. Despoina AI Mavridou  Is a corresponding author
  1. Imperial College London, United Kingdom
  2. The University of Texas at Austin, United States
  3. Universidad de Sevilla, Spain
  4. Brunel University London, United Kingdom
  5. University of Birmingham, United Kingdom
  6. Paris-Sud University, France
  7. University of Neuchatel, Switzerland

Abstract

Antimicrobial resistance in Gram-negative bacteria is one of the greatest threats to global health. New antibacterial strategies are urgently needed, and the development of antibiotic adjuvants that either neutralize resistance proteins or compromise the integrity of the cell envelope is of ever-growing interest. Most available adjuvants are only effective against specific resistance proteins. Here we demonstrate that disruption of cell envelope protein homeostasis simultaneously compromises several classes of resistance determinants. In particular, we find that impairing DsbA-mediated disulfide bond formation incapacitates diverse β-lactamases and destabilizes mobile colistin resistance enzymes. Furthermore, we show that chemical inhibition of DsbA sensitizes multidrug-resistant clinical isolates to existing antibiotics and that the absence of DsbA, in combination with antibiotic treatment, substantially increases the survival of Galleria mellonella larvae infected with multidrug-resistant Pseudomonas aeruginosa. This work lays the foundation for the development of novel antibiotic adjuvants that function as broad-acting resistance breakers.

Data availability

All data generated during this study that support the findings are included in the manuscript or in the Supplementary Information.

Article and author information

Author details

  1. R Christopher D Furniss

    Department of Life Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Nikol Kaderabkova

    Department of Molecular Biosciences, The University of Texas at Austin, Austin, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Declan Barker

    Department of Life Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Patricia Bernal

    Department of Microbiology, Universidad de Sevilla, Seville, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6228-0496
  5. Evgenia Maslova

    Department of Life Sciences, Brunel University London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Amanda AA Antwi

    Department of Life Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Helen E McNeil

    Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Hannah L Pugh

    Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Laurent Dortet

    Department of Bacteriology-Hygiene, Paris-Sud University, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Jessica MA Blair

    Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6904-4253
  11. Gerald J Larrouy-Maumus

    Department of Life Sciences, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Ronan R McCarthy

    Department of Life Sciences, Brunel University London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Diego Gonzalez

    Department of Biology, University of Neuchatel, Neuchatel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  14. Despoina AI Mavridou

    Department of Molecular Biosciences, The University of Texas at Austin, Austin, United States
    For correspondence
    despoina.mavridou@austin.utexas.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7449-1151

Funding

Medical Research Council (MR/M009505/1)

  • Despoina AI Mavridou

Swiss National Science Foundation (PZ00P3_180142)

  • Diego Gonzalez

Academy of Medical Sciences (SBF006\1040)

  • Ronan R McCarthy

National Institutes of Health (R01AI158753)

  • Despoina AI Mavridou

Biotechnology and Biological Sciences Research Council (BB/M02623X/1)

  • Jessica MA Blair

Wellcome Trust (105603/Z/14/Z)

  • Gerald J Larrouy-Maumus

British Society for Antimicrobial Chemotherapy (BSAC-2018-0095)

  • Ronan R McCarthy

Biotechnology and Biological Sciences Research Council (BB/V007823/1)

  • Ronan R McCarthy

Swiss National Science Foundation (P300PA_167703)

  • Diego Gonzalez

NC3Rs (NC/V001582/1)

  • Ronan R McCarthy

Biotechnology and Biological Sciences Research Council (BB/M011178/1)

  • Nikol Kaderabkova

Biotechnology and Biological Sciences Research Council (BB/M01116X/1)

  • Hannah L Pugh

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Melanie Blokesch, Ecole Polytechnique Fédérale de Lausanne, Switzerland

Version history

  1. Received: May 19, 2020
  2. Preprint posted: August 28, 2021 (view preprint)
  3. Accepted: January 11, 2022
  4. Accepted Manuscript published: January 13, 2022 (version 1)
  5. Version of Record published: February 22, 2022 (version 2)

Copyright

© 2022, Furniss et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 9,999
    views
  • 1,474
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. R Christopher D Furniss
  2. Nikol Kaderabkova
  3. Declan Barker
  4. Patricia Bernal
  5. Evgenia Maslova
  6. Amanda AA Antwi
  7. Helen E McNeil
  8. Hannah L Pugh
  9. Laurent Dortet
  10. Jessica MA Blair
  11. Gerald J Larrouy-Maumus
  12. Ronan R McCarthy
  13. Diego Gonzalez
  14. Despoina AI Mavridou
(2022)
Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding
eLife 11:e57974.
https://doi.org/10.7554/eLife.57974

Share this article

https://doi.org/10.7554/eLife.57974

Further reading

    1. Microbiology and Infectious Disease
    Moagi Tube Shaku, Peter K Um ... Bavesh D Kana
    Research Article

    Mechanisms by which Mycobacterium tuberculosis (Mtb) evades pathogen recognition receptor activation during infection may offer insights for the development of improved tuberculosis (TB) vaccines. Whilst Mtb elicits NOD-2 activation through host recognition of its peptidoglycan-derived muramyl dipeptide (MDP), it masks the endogenous NOD-1 ligand through amidation of glutamate at the second position in peptidoglycan side-chains. As the current BCG vaccine is derived from pathogenic mycobacteria, a similar situation prevails. To alleviate this masking ability and to potentially improve efficacy of the BCG vaccine, we used CRISPRi to inhibit expression of the essential enzyme pair, MurT-GatD, implicated in amidation of peptidoglycan side-chains. We demonstrate that depletion of these enzymes results in reduced growth, cell wall defects, increased susceptibility to antibiotics, altered spatial localization of new peptidoglycan and increased NOD-1 expression in macrophages. In cell culture experiments, training of a human monocyte cell line with this recombinant BCG yielded improved control of Mtb growth. In the murine model of TB infection, we demonstrate that depletion of MurT-GatD in BCG, which is expected to unmask the D-glutamate diaminopimelate (iE-DAP) NOD-1 ligand, yields superior prevention of TB disease compared to the standard BCG vaccine. In vitro and in vivo experiments in this study demonstrate the feasibility of gene regulation platforms such as CRISPRi to alter antigen presentation in BCG in a bespoke manner that tunes immunity towards more effective protection against TB disease.

    1. Microbiology and Infectious Disease
    Ryan Thiermann, Michael Sandler ... Suckjoon Jun
    Tools and Resources

    Despite much progress, image processing remains a significant bottleneck for high-throughput analysis of microscopy data. One popular platform for single-cell time-lapse imaging is the mother machine, which enables long-term tracking of microbial cells under precisely controlled growth conditions. While several mother machine image analysis pipelines have been developed in the past several years, adoption by a non-expert audience remains a challenge. To fill this gap, we implemented our own software, MM3, as a plugin for the multidimensional image viewer napari. napari-MM3 is a complete and modular image analysis pipeline for mother machine data, which takes advantage of the high-level interactivity of napari. Here, we give an overview of napari-MM3 and test it against several well-designed and widely used image analysis pipelines, including BACMMAN and DeLTA. Researchers often analyze mother machine data with custom scripts using varied image analysis methods, but a quantitative comparison of the output of different pipelines has been lacking. To this end, we show that key single-cell physiological parameter correlations and distributions are robust to the choice of analysis method. However, we also find that small changes in thresholding parameters can systematically alter parameters extracted from single-cell imaging experiments. Moreover, we explicitly show that in deep learning-based segmentation, ‘what you put is what you get’ (WYPIWYG) – that is, pixel-level variation in training data for cell segmentation can propagate to the model output and bias spatial and temporal measurements. Finally, while the primary purpose of this work is to introduce the image analysis software that we have developed over the last decade in our lab, we also provide information for those who want to implement mother machine-based high-throughput imaging and analysis methods in their research.